Questcor Pharmaceuticals Inc (QCOR)

93.60
1.52 1.65
NASDAQ : Health Care
Prev Close 92.08
Open 92.93
Day Low/High 92.17 / 94.42
52 Wk Low/High 47.71 / 97.80
Volume 3.18M
Avg Volume 1.57M
Exchange NASDAQ
Shares Outstanding 61.45M
Market Cap 5.75B
EPS 4.99
P/E Ratio 16.10
Div & Yield 1.20 (1.30%)
Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals was a winner within the drugs industry, rising 42 cents (1.6%) to $26.83 on light volume.

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Laggard

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Laggard

Questcor Pharmaceuticals was a leading decliner within the health care sector, falling $2.27 (-8.1%) to $25.90 on light volume.

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Winner

Questcor Pharmaceuticals was a winner within the drugs industry, rising 34 cents (1.3%) to $25.70 on light volume.

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders usually buy their own shares for one reason: They think the stock is a bargain and has tremendous upside.

Insiders Trading UNH QCOR VMW CMS

Insiders Trading UNH QCOR VMW CMS

The top 10 open-market insider purchases and sales filed at the SEC Tuesday.

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner

Questcor Pharmaceuticals was a winner within the health care sector, rising 82 cents (3.4%) to $24.96 on light volume.

Lieff Cabraser Reminds Questcor Pharmaceuticals, Inc. Investors Of Upcoming Deadline In Class Action Lawsuits

Lieff Cabraser Reminds Questcor Pharmaceuticals, Inc. Investors Of Upcoming Deadline In Class Action Lawsuits

Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the November 26, 2012 deadline to move for appointment as lead plaintiff in the securities class litigation against Questcor Pharmaceuticals,...

Questcor Stock To Go Ex-dividend Monday (QCOR)

Questcor Stock To Go Ex-dividend Monday (QCOR)

The ex-dividend date for Questcor Pharmaceuticals (Nasdaq:QCOR) is Monday, October 29, 2012. Owners of shares as of market close today will be eligible for a dividend of 20 cents per share. At a price of $26.26 as of 9:30 a.m., the dividend yield is 3.1%.

Questcor Pharmaceuticals Inc. Stock Downgraded (QCOR)

Questcor Pharmaceuticals Inc. Stock Downgraded (QCOR)

Questcor Pharmaceuticals (Nasdaq:QCOR) has been downgraded by TheStreet Ratings from from a buy to hold.

Lieff Cabraser Announces Class Action Lawsuits Against Questcor Pharmaceuticals, Inc.

Lieff Cabraser Announces Class Action Lawsuits Against Questcor Pharmaceuticals, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action lawsuits have been brought on behalf of all persons who purchased or otherwise acquired the securities of Questcor...

Cramer's 'Mad Money' Recap: The Benefit of Doing Nothing

Cramer's 'Mad Money' Recap: The Benefit of Doing Nothing

Thanks to European and Chinese inaction, American companies have been able to adjust and profit.

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Health Care Winner

Questcor Pharmaceuticals was a winner within the health care sector, rising 89 cents (4.6%) to $20.29 on average volume.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.

Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit On Behalf Of Questcor Pharmaceuticals, Inc. Investors

Wolf Haldenstein Adler Freeman & Herz LLP Commences Class Action Lawsuit On Behalf Of Questcor Pharmaceuticals, Inc. Investors

Wolf Haldenstein Adler Freeman & Herz LLP has filed a class action lawsuit in the United States District Court, Central District of California, on behalf of all persons who purchased the common stock of Questcor...

Newman Ferrara LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Questcor Pharmaceuticals, Inc.

Newman Ferrara LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Questcor Pharmaceuticals, Inc.

Newman Ferrara LLP announces that a class action lawsuit has been filed in the Central District of California against Questcor Pharmaceuticals, Inc.

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Questcor Pharmaceuticals, Inc.

Ryan & Maniskas, LLP ( www.rmclasslaw.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Questcor Pharmaceuticals Inc. For Securities Fraud

Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Questcor Pharmaceuticals Inc. For Securities Fraud

Shareholder Rights Law Firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Questcor Pharmaceuticals Inc.

The 5 Dumbest Things on Wall Street This Week: Sept. 28

The 5 Dumbest Things on Wall Street This Week: Sept. 28

Blyth's Catch-22; Questcor Crumbles; Musk's Macho Mess; RIM's Terrible Timing; Intel Bugs Buddy.

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals Inc. (QCOR): Today's Featured Drugs Laggard

Questcor Pharmaceuticals was a leading decliner within the drugs industry, falling 41 cents (-2.3%) to $17.83 on average volume.

Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation By Goldfarb LLP Securities Lawyers

Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation By Goldfarb LLP Securities Lawyers

Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Questor Pharmaceuticals.

Questcor Pharmaceuticals Investor Alert – The Briscoe Law Firm And Powers Taylor, LLP Announce Investigation For Possible Violations Of Securities Laws

Questcor Pharmaceuticals Investor Alert – The Briscoe Law Firm And Powers Taylor, LLP Announce Investigation For Possible Violations Of Securities Laws

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor, LLP announce that the firms are...

Stocks Slide on Eurozone Worries, Apple

Stocks Slide on Eurozone Worries, Apple

The major U.S. equity averages finish with slight losses as Europe continues to struggle with how to deal with its debt problems.

Options 'Flow' Foretold Questcor Plunge

Options 'Flow' Foretold Questcor Plunge

Tony Pelz shows investors how to monitor unusual options trades to manage risk.

A Volatility Trade on BBBY

A Volatility Trade on BBBY

Disappointing earnings results have sent this name cascading lower. 

Questcor Rises On Unusually High Volume (QCOR)

Questcor Rises On Unusually High Volume (QCOR)

Questcor Pharmaceuticals (Nasdaq:QCOR) is trading at unusually high volume Thursday with 11 million shares changing hands. It is currently at 4.3 times its average daily volume and trading up $3.52 (+13.4%).

Analysts' Actions: AWK GS PHM NVE QCOR X

Analysts' Actions: AWK GS PHM NVE QCOR X

Here are today's top research calls.